Tag Archives: Genome editing

How do Ordre public and morality exceptions in the EPC and EU Biotechnology directive apply to stem cell and genome editing inventions, compare those with s.101 US patent code, different between US and EPO/EU approach

– Making comparisons between stem cell and genome editing (CRISPR) to good effect – How do Ordre public and morality exceptions in the EPC and EU Biotechnology directive apply to stem cell and genome editing inventions, compare those with s.101 US patent code, different between US and EPO/EU approach – Why the morality exception and […]